Skip to main content
. 2017 Sep 6;8(46):81501–81510. doi: 10.18632/oncotarget.20662

Table 4. Adverse events (AE/SAE) by patient.

Patient AE/SAE and grade
1 Grade 4 anemia, neutropenia and thrombocytopenia. Did not recover ≤ Grade 2 in 2 weeks, off study
2 None
3 Grade 4 neutropenia and thrombocytopenia at 400 mg bid; Grade 5 sepsis
4 Grade 3 neutropenia at 300 mg bid
5 Grade 3 neutropenia at 300 mg bid; none at 215 mg bid
6 Grade 1 paresthesias
7 None
8 Grade 3 neutropenia at 300 mg bid; Grade 2 at 215 mg bid, off study
9 None